U.S. prosecutors say a fugitive linked to a massive Medicare fraud scheme was arrested. The alleged operation centered on medically unnecessary genetic testing and deceptive marketing tied to patient recruiters, telemarketing call centers, and kickbacks/bribes.

The U.S. Department of Justice announced the arrest of a fugitive accused of involvement in an alleged $547 million Medicare fraud scheme. Prosecutors say the conspiracy relied on medically unnecessary genetic testing marketed to Medicare beneficiaries through deceptive promotional tactics. The government alleges that the fraud network used coordinated recruiting and outreach components, including patient recruiters and telemarketing call centers, to generate leads and steer individuals into the testing pipeline. A key feature of the alleged scheme was the use of kickbacks and bribes to influence referrals and participation in the testing program. DOJ’s announcement indicates the fraud was not limited to marketing materials; it also involved operational mechanisms designed to generate volume and sustain the scheme long enough to produce large Medicare-related losses. While the DOJ filing reflects allegations rather than proven facts, the announced arrest underscores a major pattern in health-care fraud cases: large-scale deception tied to billing practices, combined with sales-style operations that pressure or incentivize patients and intermediaries. For consumers and providers, the case illustrates how aggressive outreach and misleading claims can be used to funnel people into unnecessary services, eventually translating into fraudulent claims to federal programs.